Get started
Author

Liliana Montella

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance
2009 · Raffaele Addeo, Michele Caraglia, et al. · Journal of Clinical Oncology · 191
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
2010 · Bruno Vincenzi, Daniele Santini, et al. · The Oncologist · 176
PDF
Somatostatin analogs and prednisone in advanced refractory thymic tumors
2002 · Giovannella Palmieri, Liliana Montella, et al. · Cancer · 104
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
2011 · M Caraglia, G Giuberti, et al. · Cell Death and Disease · 94
PDF
Low-Dose Metronomic Oral Administration of Vinorelbine in the First-line Treatment of Elderly Patients With Metastatic Breast Cancer
2010 · Raffaele Addeo, Alessandro Sgambato, et al. · Clinical Breast Cancer · 94
Phase 2 trial of temozolomide using protracted low‐dose and whole‐brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases
2008 · Raffaele Addeo, Carmine De Rosa, et al. · Cancer · 90
PDF
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study
2009 · Salvatore Del Prete, Liliana Montella, et al. · Cancer Chemotherapy and Pharmacology · 77
Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life
2007 · Raffaele Addeo, Michele Caraglia, et al. · BMC Cancer · 75
PDF
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
2010 · Raffaele Addeo, Michele Caraglia, et al. · Journal of Neuro-Oncology · 70
PDF
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
2005 · Michele Caraglia, Raffaele Addeo, et al. · Cancer Chemotherapy and Pharmacology · 70
Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
2009 · G. Palmieri, G. Merola, et al. · Annals of Oncology · 57
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis
2020 · Carlo Buonerba, Matteo Ferro, et al. · Critical Reviews in Oncology/Hematology · 54
Glutathione: Lights and Shadows in Cancer Patients
2023 · Herbert Ryan Marini, Bianca Arianna Facchini, et al. · Biomedicines · 52
PDF
Imatinib Mesylate for Cerebral Langerhans'-Cell Histiocytosis
2004 · Liliana Montella, Luigi Insabato, et al. · New England Journal of Medicine · 50
PDF
B-cell lymphopenia and hypogammaglobulinemia in thymoma patients
2003 · L. Montella, A. M. Masci, et al. · Annals of Hematology · 49
Capecitabine Plus Gemcitabine in Thymic Epithelial Tumors: Final Analysis of a Phase II Trial
2014 · Giovannella Palmieri, Carlo Buonerba, et al. · Future Oncology · 45
Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia
2003 · A. M. Masci, G. Palmieri, et al. · Blood · 44
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases
2012 · Raffaele Addeo, Pasquale Sperlongano, et al. · Cancer Chemotherapy and Pharmacology · 40
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age
2007 · Raffaele Addeo, Vincenzo Faiola, et al. · Cancer Chemotherapy and Pharmacology · 40
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway
2022 · Nunzio Del Gaudio, Antonella Di Costanzo, et al. · Molecular Cancer · 38
PDF
Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
2022 · Margaret Ottaviano, Emilio Francesco Giunta, et al. · Biomedicines · 37
PDF
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience
2019 · Salvatore Del Prete, Michele Caraglia, et al. · Oncology Letters · 34
PDF
Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
2016 · Liliana Montella, Giovannella Palmieri, et al. · World Journal of Gastroenterology · 33
PDF
Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report.
2000 · G Palmieri, L Montella, et al. · Oncology Reports · 33
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
2009 · Liliana Montella, Raffaele Addeo, et al. · Cancer Chemotherapy and Pharmacology · 32
Works count: 140
Citation count: 2,374
H-index: 28
I10-index: 52
Year
Topic
Type